The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Keen Nicholas since 2021.
This trader's CIK number is 1776881.
At the time of last reporting, Keen Nicholas was the CHIEF SCIENTIFIC OFFICER of Bicycle Therapeutics Plc. (stock ticker symbol BCYC).
Also see all insider trading activities at Bicycle Therapeutics Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | BCYC | 0 | $0 | 4,209 | $80,308 | 0 | $0 |
| 2023 | BCYC | 0 | $0 | 2,744 | $73,409 | 0 | $0 |
| 2021 | BCYC | 0 | $0 | 48,321 | $1,711,920 | 15,477 | $216,678 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-07-03 | BCYC | Sale | 779 | 19.64 | 15,299 |
| 2024-04-03 | BCYC | Sale | 790 | 23.81 | 18,809 |
| 2024-01-03 | BCYC | Sale | 2,640 | 17.50 | 46,200 |
| 2023-10-03 | BCYC | Sale | 272 | 20.00 | 5,440 |
| 2023-07-03 | BCYC | Sale | 336 | 25.10 | 8,433 |
| 2023-04-03 | BCYC | Sale | 319 | 21.11 | 6,734 |
| 2023-01-03 | BCYC | Sale | 1,817 | 29.06 | 52,802 |
| 2021-12-21 | BCYC | Option Ex | 15,477 | 14.00 | 216,678 |
| 2021-10-05 | BCYC | Sale | 2,178 | 45.10 | 98,227 |
| 2021-10-01 | BCYC | Sale | 1,188 | 45.00 | 53,460 |
| 2021-09-16 | BCYC | Sale | 1,955 | 45.01 | 87,994 |
| 2021-09-15 | BCYC | Sale | 3,000 | 45.00 | 135,000 |
| 2021-09-02 | BCYC | Sale | 10,000 | 40.00 | 400,000 |
| 2021-07-14 | BCYC | Sale | 10,000 | 35.00 | 350,000 |
| 2021-03-31 | BCYC | Sale | 10,000 | 30.00 | 300,000 |
| 2021-03-12 | BCYC | Sale | 9,783 | 28.74 | 281,163 |
| 2021-03-15 | BCYC | Sale | 217 | 28.00 | 6,076 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Keen Nicholas (CHIEF SCIENTIFIC OFFICER of Bicycle Therapeutics Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.